Pacira BioSciences Inc. has entered into a new Credit Agreement with Wells Fargo Bank, National Association, and other lenders as of July 3, 2025. This agreement involves a senior secured revolving credit facility with a commitment amount of $300 million, aimed at refinancing Pacira's previous term loan A facility and providing ongoing working capital. The facility, which matures on July 3, 2030, includes a $10 million letter of credit sublimit and a $15 million swingline loan sublimit, secured by the assets of the company and its subsidiaries. The new arrangement allows for potential expansion through incremental term facilities. Notably, Pacira terminated its existing credit agreement without incurring prepayment penalties.